S. Armoni

1.1k total citations
19 papers, 802 citations indexed

About

S. Armoni is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, S. Armoni has authored 19 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 3 papers in Infectious Diseases and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in S. Armoni's work include Cystic Fibrosis Research Advances (16 papers), Neonatal Respiratory Health Research (5 papers) and Antifungal resistance and susceptibility (3 papers). S. Armoni is often cited by papers focused on Cystic Fibrosis Research Advances (16 papers), Neonatal Respiratory Health Research (5 papers) and Antifungal resistance and susceptibility (3 papers). S. Armoni collaborates with scholars based in Israel, United States and United Kingdom. S. Armoni's co-authors include Eitan Kerem, David Shoseyov, Michael Wilschanski, Micha Aviram, Hannah Blau, Joseph Rivlin, Gary Elfring, Samit Hirawat, Michael Cohen and Yasmin Yaakov and has published in prestigious journals such as The Lancet, CHEST Journal and European Respiratory Journal.

In The Last Decade

S. Armoni

18 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Armoni Israel 10 558 238 92 71 58 19 802
Claudine Guilbault Canada 11 386 0.7× 237 1.0× 90 1.0× 27 0.4× 44 0.8× 13 647
Rhonda G. Pace United States 17 841 1.5× 223 0.9× 67 0.7× 89 1.3× 115 2.0× 35 1.1k
C Simard United States 7 1.6k 2.9× 287 1.2× 203 2.2× 93 1.3× 93 1.6× 22 1.9k
Stephanie Hirtz Germany 15 814 1.5× 146 0.6× 142 1.5× 69 1.0× 43 0.7× 23 985
Jennifer S. Guimbellot United States 16 496 0.9× 159 0.7× 46 0.5× 21 0.3× 49 0.8× 39 663
Deborah M. Cholon United States 13 661 1.2× 181 0.8× 122 1.3× 29 0.4× 24 0.4× 20 822
Andréa Novais Moreno-Amaral Brazil 17 86 0.2× 201 0.8× 129 1.4× 28 0.4× 36 0.6× 32 676
Amarjit Mishra United States 15 157 0.3× 209 0.9× 86 0.9× 12 0.2× 57 1.0× 35 592
R. Cagnina United States 9 160 0.3× 74 0.3× 29 0.3× 52 0.7× 37 0.6× 18 501
Brian Sims United States 16 202 0.4× 442 1.9× 34 0.4× 19 0.3× 62 1.1× 36 821

Countries citing papers authored by S. Armoni

Since Specialization
Citations

This map shows the geographic impact of S. Armoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Armoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Armoni more than expected).

Fields of papers citing papers by S. Armoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Armoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Armoni. The network helps show where S. Armoni may publish in the future.

Co-authorship network of co-authors of S. Armoni

This figure shows the co-authorship network connecting the top 25 collaborators of S. Armoni. A scholar is included among the top collaborators of S. Armoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Armoni. S. Armoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Shoseyov, David, et al.. (2022). Respiratory physiotherapy in patients with cystic fibrosis and upper limb deep vein thrombosis. Pediatric Pulmonology. 57(6). 1552–1554. 1 indexed citations
2.
Gileles‐Hillel, Alex, Oded Breuer, S. Armoni, et al.. (2022). The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis‐related diabetes. Pediatric Pulmonology. 57(11). 2774–2780. 1 indexed citations
3.
Shoseyov, David, et al.. (2018). Increasing Vitamin D Serum Levels Is Associated With Reduced Pulmonary Exacerbations in Patients With Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 68(1). 110–115. 16 indexed citations
4.
Cohen‐Cymberknoh, Malena, Silvia Gärtner, Hannah Blau, et al.. (2016). Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis. Journal of Cystic Fibrosis. 15(6). 776–782. 30 indexed citations
5.
Breuer, Oded, et al.. (2015). CFTR potentiator therapy ameliorates impaired insulin secretion in CF patients with a gating mutation. Journal of Cystic Fibrosis. 15(3). e25–e27. 50 indexed citations
6.
Pugatsch, Thea, David Shoseyov, Malena Cohen‐Cymberknoh, et al.. (2015). Adherence pattern to study drugs in clinical trials by patients with cystic fibrosis. Pediatric Pulmonology. 51(2). 143–146. 7 indexed citations
7.
Shoseyov, David, et al.. (2015). WS04.5 Vitamin D influence on respiratory exacerbations and hospitalizations in cystic fibrosis patients. Journal of Cystic Fibrosis. 14. S8–S8. 1 indexed citations
8.
Wilschanski, Michael, L.L. Miller, David Shoseyov, et al.. (2011). Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. European Respiratory Journal. 38(1). 59–69. 151 indexed citations
9.
Werlin, Steven L., Eitan Kerem, Eran Goldin, et al.. (2010). Evidence of Intestinal Inflammation in Patients With Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 51(3). 304–308. 133 indexed citations
10.
Cohen‐Cymberknoh, Malena, Hannah Blau, David Shoseyov, et al.. (2009). Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis. Journal of Cystic Fibrosis. 8(4). 253–257. 56 indexed citations
11.
Kerem, Eitan, Sebastian Bauer, N Jaffe, et al.. (2009). Safety and Efficacy of Inhaled Human Alpha-1 Antitrypsin (AAT) in Cystic Fibrosis (CF): A Report of a Phase II Clinical Study.. A1185–A1185. 6 indexed citations
12.
Klein, Martine, Malena Cohen‐Cymberknoh, S. Armoni, et al.. (2009). 18 F-Fluorodeoxyglucose-PET/CT Imaging of Lungs in Patients With Cystic Fibrosis. CHEST Journal. 136(5). 1220–1228. 33 indexed citations
13.
Cohen‐Cymberknoh, Malena, Hannah Blau, David Shoseyov, et al.. (2009). Intravenous Monthly High-Dose Pulse Methylprednisolone vs Oral Prednisone for Therapy of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.. A1184–A1184. 2 indexed citations
14.
Kerem, Eitan, et al.. (2009). Safety/Efficacy of Inhaled Human Alpha-1 Antitrypsin (AAT) in CF: A Phase II Clinical Study. Journal of Cystic Fibrosis. 8. S25–S25. 3 indexed citations
15.
Kerem, Eitan, Samit Hirawat, S. Armoni, et al.. (2008). Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. The Lancet. 372(9640). 719–727. 290 indexed citations
16.
Cohen‐Cymberknoh, Malena, et al.. (2008). Intravenous methylprednisolone pulse therapy vs. oral prednisone for allergic bronchopulmonary aspergillosis (ABPA) in CF. Journal of Cystic Fibrosis. 7. S58–S58. 9 indexed citations
17.
Wilschanski, M., S. Armoni, Yasmin Yaakov, et al.. (2008). PTC124 treatment over 3 months improves pharmacodynamic and clinical parameters in patients with nonsense-mutation-mediated CF. Journal of Cystic Fibrosis. 7. S22–S22. 10 indexed citations
18.
Shoseyov, David, et al.. (2008). Impaired glucose metabolism in patients with CF during acute exacerbations. Journal of Cystic Fibrosis. 7. S83–S83. 1 indexed citations
19.
Kerem, Eitan, Samit Hirawat, S. Armoni, et al.. (2007). 41* PTC124 activity in CF patients carrying stop mutations: results of a phase 2 study. Journal of Cystic Fibrosis. 6. S10–S10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudine Guilbault Breakdown of academic impact, for papers by Rhonda G. Pace Breakdown of academic impact, for papers by C Simard Breakdown of academic impact, for papers by Stephanie Hirtz Breakdown of academic impact, for papers by Jennifer S. Guimbellot Breakdown of academic impact, for papers by Deborah M. Cholon Breakdown of academic impact, for papers by Andréa Novais Moreno-Amaral Breakdown of academic impact, for papers by Amarjit Mishra Breakdown of academic impact, for papers by R. Cagnina Breakdown of academic impact, for papers by Brian Sims
Rankless by CCL
2026